Mehta RG - Search Results

1

Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapy.

Hussain EA, Mehta RR, Ray R, Das Gupta TK, Mehta RG. Hussain EA, et al. Among authors: mehta rg, mehta rr. Recent Results Cancer Res. 2003;164:393-411. doi: 10.1007/978-3-642-55580-0_29. Recent Results Cancer Res. 2003. PMID: 12899538 Review.

2

Growth inhibition of carcinogen-transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1alpha-hydroxyvitamin D5.

Hussain-Hakimjee EA, Peng X, Mehta RR, Mehta RG. Hussain-Hakimjee EA, et al. Among authors: mehta rg, mehta rr. Carcinogenesis. 2006 Mar;27(3):551-9. doi: 10.1093/carcin/bgi231. Epub 2005 Sep 29. Carcinogenesis. 2006. PMID: 16195238

3

Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells.

Peng X, Mehta R, Wang S, Chellappan S, Mehta RG. Peng X, et al. Among authors: mehta rg, mehta r. Cancer Res. 2006 Jul 15;66(14):7361-9. doi: 10.1158/0008-5472.CAN-06-1004. Cancer Res. 2006. PMID: 16849588

4

Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D.

Mehta RG, Hussain EA, Mehta RR, Das Gupta TK. Mehta RG, et al. Among authors: mehta rr. Mutat Res. 2003 Feb-Mar;523-524:253-64. doi: 10.1016/s0027-5107(02)00341-x. Mutat Res. 2003. PMID: 12628523

5

Induction of differentiation by 1alpha-hydroxyvitamin D(5) in T47D human breast cancer cells and its interaction with vitamin D receptors.

Lazzaro G, Agadir A, Qing W, Poria M, Mehta RR, Moriarty RM, Das Gupta TK, Zhang XK, Mehta RG. Lazzaro G, et al. Among authors: mehta rg, mehta rr. Eur J Cancer. 2000 Apr;36(6):780-6. doi: 10.1016/s0959-8049(00)00016-2. Eur J Cancer. 2000. PMID: 10762752

6

Clinical trials using chemopreventive vitamin D analogs in breast cancer.

Vijayakumar S, Boerner PS, Mehta RR, Packianathan S, Mehta RG, Das Gupta TK. Vijayakumar S, et al. Among authors: mehta rg, mehta rr. Cancer J. 2006 Nov-Dec;12(6):445-50. doi: 10.1097/00130404-200611000-00001. Cancer J. 2006. PMID: 17207311 Review.

7

A 28-amino-acid peptide fragment of the cupredoxin azurin prevents carcinogen-induced mouse mammary lesions.

Mehta RR, Hawthorne M, Peng X, Shilkaitis A, Mehta RG, Beattie CW, Das Gupta TK. Mehta RR, et al. Among authors: mehta rg. Cancer Prev Res (Phila). 2010 Oct;3(10):1351-60. doi: 10.1158/1940-6207.CAPR-10-0024. Epub 2010 Sep 14. Cancer Prev Res (Phila). 2010. PMID: 20841487

8

Vitamin D and breast cancer: emerging concepts.

Mehta RG, Peng X, Alimirah F, Murillo G, Mehta R. Mehta RG, et al. Among authors: mehta r. Cancer Lett. 2013 Jun 28;334(1):95-100. doi: 10.1016/j.canlet.2012.10.034. Epub 2012 Nov 8. Cancer Lett. 2013. PMID: 23142286 Review.

9

Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cells.

Mehta RR, Katta H, Kalra A, Patel R, Gupta A, Alimirah F, Murillo G, Peng X, Unni A, Muzzio M, Mehta RG. Mehta RR, et al. Among authors: mehta rg. Clin Exp Metastasis. 2013 Oct;30(7):855-66. doi: 10.1007/s10585-013-9585-6. Epub 2013 May 5. Clin Exp Metastasis. 2013. PMID: 23645347 Free PMC article.

10

Vitamin D and cancer.

Mehta RG, Mehta RR. Mehta RG, et al. Among authors: mehta rr. J Nutr Biochem. 2002 May;13(5):252-264. doi: 10.1016/s0955-2863(02)00183-3. J Nutr Biochem. 2002. PMID: 12015155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page